Dr Bob Arnots Pain Pen
NDC Package 54641-002-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Dr Bob Arnots Pain Pen is a . Marketed by Larasan Pharmaceutical Corporation, this product is identified by NDC 54641-002 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
54641-002-02
Package Description
10 mL in 1 BOTTLE, WITH APPLICATOR
Product Code
54641-002
11-Digit Billing Format
54641000202

Clinical Specifications

Proprietary Name
Dr Bob Arnots Pain Pen
Dosage Form
-

Regulatory & Marketing

Labeler Name
Larasan Pharmaceutical Corporation
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
01-08-2013
End Marketing Date
02-05-2017
Listing Expiration
02-05-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 54641-002-02 identifies a specific commercial package of 10 ml in 1 bottle, with applicator of Dr Bob Arnots Pain Pen, labeled by Larasan Pharmaceutical Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Larasan Pharmaceutical Corporation on January 08, 2013. The current certification is valid through February 05, 2017.

How is this Larasan Pharmaceutical Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 54641000202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
54641-002-02
11-Digit CMS (5-4-2)
54641-0002-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.